Full text
PDF![1766](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/1a3f8e011bc2/jcinvest00630-0048.png)
![1767](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/bc25144d69a4/jcinvest00630-0049.png)
![1768](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/03e4a92db295/jcinvest00630-0050.png)
![1769](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/d8373ceaf1b4/jcinvest00630-0051.png)
![1770](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/02fb01ddbf15/jcinvest00630-0052.png)
![1771](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/cbf9931d5a7d/jcinvest00630-0053.png)
![1772](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/f20dad59eb2f/jcinvest00630-0054.png)
![1773](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/fa3ac58ff855/jcinvest00630-0055.png)
![1774](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/49c762f19472/jcinvest00630-0056.png)
![1775](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/cb3eaed957b7/jcinvest00630-0057.png)
![1776](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/f413d32e8cc4/jcinvest00630-0058.png)
![1777](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/097bc13c15ed/jcinvest00630-0059.png)
![1778](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c3/438760/8d95d2a34b14/jcinvest00630-0060.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEARN A. G., KUNKEL H. G. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria. J Clin Invest. 1954 Mar;33(3):400–409. doi: 10.1172/JCI102912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BEARN A. G., KUNKEL H. G. Localization of Cu64 in serum fractions following oral administration: an alteration in Wilson's disease. Proc Soc Exp Biol Med. 1954 Jan;85(1):44–48. doi: 10.3181/00379727-85-20780. [DOI] [PubMed] [Google Scholar]
- BEARN A. G., KUNKEL H. G. Metabolic studies in Wilson's disease using Cu64. J Lab Clin Med. 1955 Apr;45(4):623–631. [PubMed] [Google Scholar]
- CARTWRIGHT G. E., GUBLER C. J., WINTROBE M. M. Studies on copper metabolism. XI. Copper and iron metabolism in the nephrotic syndrome. J Clin Invest. 1954 Apr;33(4):685–698. doi: 10.1172/JCI102939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CARTWRIGHT G. E., HODGES R. E., GUBLER C. J., MAHONEY J. P., DAUM K., WINTROBE M. M., BEAN W. B. Studies on copper metabolism. XIII. Hepatolenticular degeneration. J Clin Invest. 1954 Nov;33(11):1487–1501. doi: 10.1172/JCI103027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DENNY-BROWN D., PORTER H. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med. 1951 Dec 13;245(24):917–925. doi: 10.1056/NEJM195112132452401. [DOI] [PubMed] [Google Scholar]
- EARL C. J., MOULTON M. J., SELVERSTONE B. Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64. Am J Med. 1954 Aug;17(2):205–213. doi: 10.1016/0002-9343(54)90258-2. [DOI] [PubMed] [Google Scholar]
- GUBLER C. J., LAHEY M. E., ASHENBRUCKER H., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism I. A method for the determination of copper in whole blood, red blood cells, and plasma. J Biol Chem. 1952 May;196(1):209–220. [PubMed] [Google Scholar]
- GUBLER C. J., LAHEY M. E., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. IX. The transportation of copper in blood. J Clin Invest. 1953 May;32(5):405–414. doi: 10.1172/JCI102752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HUFF R. L., ELMLINGER P. J., GARCIA J. F., ODA J. M., COCKRELL M. C., LAWRENCE J. H. Ferrokinetics in normal persons and in patients having various erythropoietic disorders. J Clin Invest. 1951 Dec;30(122):1512–1526. doi: 10.1172/JCI102562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MARKOWITZ H., GUBLER C. J., MAHONEY J. P., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. J Clin Invest. 1955 Oct;34(10):1498–1508. doi: 10.1172/JCI103201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MATTHEWS W. B. The absorption and excretion of radiocopper in hepato-lenticular degeneration (Wilson's disease). J Neurol Neurosurg Psychiatry. 1954 Nov;17(4):242–246. doi: 10.1136/jnnp.17.4.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
- ZIMDAHL W. T., HYMAN I., COOK E. D. Metabolism of copper in hepatolenticular degeneration. Neurology. 1953 Aug;3(8):569–576. doi: 10.1212/wnl.3.8.569. [DOI] [PubMed] [Google Scholar]